This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. 3/24/2008 It is well accepted that reduced cognitive functioning,33 depression34 and fatigue35-37 are much more prevalent in individuals with TBI than in the general population, and the treatment of these disorders represents a key challenge to the rehabilitation and improved quality of life of persons with TBI. Although aerobic exercise has been shown to improve cognition and mood in the general population,38-45 research in individuals with TBI is limited.46-50 However, exercise has been shown to be effective in improving cognition, depression and fatigue in individuals with other medical conditions, such as cancer,51 multiple sclerosis (MS),52 fibromyalgia,53 dementia,54-56 chronic fatigue syndrome,57 chronic obstructive pulmonary disease,58 and in the elderly.44,59,60 While an aerobic exercise treatment program may be similarly effective for individuals with TBI, research does not yet support this premise. The proposed study will a) examine the efficacy of an aerobic exercise intervention for improving cognition, depression and fatigue after TBI, b) evaluate the effect of post-TBI exercise on life satisfaction, and c) explore personal and injury characteristics that mediate effectiveness of aerobic exercise in individuals with TBI. The effects of the intervention will be examined using a randomized clinical trial with a crossover design evaluating objective and subjective effects of a 16-week aerobic exercise program. More specifically, each person will undergo individual interviews, self reports and neuropsychological testing aimed at measuring cognition, mood, fatigue, and life satisfaction. Approximately 112 individuals who meet all eligibility criteria are expected to complete the entire study. Assessment of cognition, mood, fatigue, and life satisfaction will occur prior to beginning the intervention, immediately after the intervention and three months post-intervention. The study will also examine the role of neurotropic growth factors (BDNF and VEGF) in improving emotional function, cognitive performance, and fatigue. Hypothesis: Cognitive functioning, mood, and fatigue symptoms will improve following eight weeks of exercise intervention. This improvement will correlate with increased BDNF and VEGF levels.

Agency
National Institute of Health (NIH)
Institute
National Center for Research Resources (NCRR)
Type
General Clinical Research Centers Program (M01)
Project #
5M01RR000071-46
Application #
7953727
Study Section
National Center for Research Resources Initial Review Group (RIRG)
Project Start
2009-03-01
Project End
2009-07-31
Budget Start
2009-03-01
Budget End
2009-07-31
Support Year
46
Fiscal Year
2009
Total Cost
$2,692
Indirect Cost
Name
Icahn School of Medicine at Mount Sinai
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
078861598
City
New York
State
NY
Country
United States
Zip Code
10029
Grams, Morgan E; Sang, Yingying; Ballew, Shoshana H et al. (2018) Predicting timing of clinical outcomes in patients with chronic kidney disease and severely decreased glomerular filtration rate. Kidney Int 93:1442-1451
Kattan, Meyer; Bacharier, Leonard B; O'Connor, George T et al. (2018) Spirometry and Impulse Oscillometry in Preschool Children: Acceptability and Relationship to Maternal Smoking in Pregnancy. J Allergy Clin Immunol Pract 6:1596-1603.e6
Coplan, Jeremy D; Webler, Ryan; Gopinath, Srinath et al. (2018) Neurobiology of the dorsolateral prefrontal cortex in GAD: Aberrant neurometabolic correlation to hippocampus and relationship to anxiety sensitivity and IQ. J Affect Disord 229:1-13
Altman, Matthew C; Whalen, Elizabeth; Togias, Alkis et al. (2018) Allergen-induced activation of natural killer cells represents an early-life immune response in the development of allergic asthma. J Allergy Clin Immunol 142:1856-1866
Juraschek, Stephen P; Miller 3rd, Edgar R; Appel, Lawrence J (2018) Orthostatic Hypotension and Symptoms in the AASK Trial. Am J Hypertens 31:665-671
Chen, Teresa K; Appel, Lawrence J; Grams, Morgan E et al. (2017) APOL1 Risk Variants and Cardiovascular Disease: Results From the AASK (African American Study of Kidney Disease and Hypertension). Arterioscler Thromb Vasc Biol 37:1765-1769
Ku, Elaine; Gassman, Jennifer; Appel, Lawrence J et al. (2017) BP Control and Long-Term Risk of ESRD and Mortality. J Am Soc Nephrol 28:671-677
Anderegg, Nanina; Johnson, Leigh F; Zaniewski, Elizabeth et al. (2017) All-cause mortality in HIV-positive adults starting combination antiretroviral therapy: correcting for loss to follow-up. AIDS 31 Suppl 1:S31-S40
Gern, James E; Calatroni, Agustin; Jaffee, Katy F et al. (2017) Patterns of immune development in urban preschoolers with recurrent wheeze and/or atopy. J Allergy Clin Immunol 140:836-844.e7
Abdallah, Chadi G; Jackowski, Andrea; Salas, Ramiro et al. (2017) The Nucleus Accumbens and Ketamine Treatment in Major Depressive Disorder. Neuropsychopharmacology 42:1739-1746

Showing the most recent 10 out of 869 publications